Eric Perakslis, PhD
Chief Science and Digital Officer, Duke Clinical Research Institute
Eric Perakslis, PhD, is the Chief Science and Digital Officer at the Duke Clinical Research Institute & Professor of Population Health Sciences at the Duke University School of Medicine.
Prior to his appointment, Eric was a Rubenstein Fellow at Duke University, focused on collaborative efforts spanning medicine, policy, engineering, information technology and security. Immediately prior to his arrival at Duke, Eric served as CSO at Datavant, Lecturer in the Department of Biomedical Informatics at Harvard Medical School, and Strategic Innovation Advisor to Médecins Sans Frontières.
Eric was a Senior Vice President and Head of the Takeda R&D Data Science Institute, where he built an integrated institute serving all aspects of biopharmaceutical R&D and digital health. Prior to Takeda, Eric was the Executive Director of the Center for Biomedical Informatics and the Countway Library of Medicine, an Instructor in Pediatrics at Harvard Medical School, and a faculty member at the Children’s Hospital Informatics Program at Boston Children’s Hospital.
Eric has served as Chief Information Officer and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. During his time at the FDA, he authored the first IT Strategic Plan and was responsible for modernizing, enhancing the IT capabilities and in silico scientific capabilities.
Prior to Eric’s FDA role, he was Senior Vice President of R&D Information Technology at Johnson & Johnson Pharmaceuticals R&D and a member of the Corporate Office of Science & Technology. While at J&J, he created and open-sourced the tranSMART clinical data system, which is now being freely used by hundreds of healthcare organizations. During his 13 years at J&J, Eric also held the posts of VP R&D Informatics, Director of Research Information Technology and Director of Drug Discovery Research.
Eric currently serves on multiple SABs, Boards of Directors and actively advises many biotech and digital health companies.